Foghorn Therapeutics FHTX
NASDAQ FHTX
$2.09 +0.19 (+10.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Foghorn Therapeutics (FHTX) Other Operating Expenses (2024 - 2025)

Updated

Foghorn Therapeutics (FHTX) reported Other Operating Expenses of $4.28 million for Q4 2025.

Analysis

Foghorn Therapeutics (FHTX) Other Operating Expenses (2024 - 2025) Analysis & Trends

  • By year, Other Operating Expenses came in at $2.4 million in FY2024.
  • The Q4 2025 figure ranks as the lowest quarterly Other Operating Expenses since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Foghorn Therapeutics 113.93 Mn -202.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.28 Mn
Jun 30, 2024 2.40 Mn
API Access

Foghorn Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=FHTX&period=max&api_key=YOUR_API_KEY